Biological Regulation of HIF-1α and Its Role in Therapeutic Angiogenesis for Treatment of Ischemic Cardiovascular Disease
Document Type
Journal Article
Publication Date
11-20-2025
Journal
International journal of molecular sciences
Volume
26
Issue
22
DOI
10.3390/ijms262211236
Keywords
HIF-1α; cardiovascular diseases; hypoxia; ischemia; oxygen
Abstract
Hypoxia, characterized by insufficient oxygen saturation, triggers a wide array of vascular responses aimed at enhancing cell survival and proliferation. This process is primarily driven by the activation of oxygen-sensing hypoxia-inducible factors (HIFs). HIF-1α, a key mediator in this context, plays a crucial role in vascular restructuring in response to low oxygen tension and oxygen-independent signaling pathways, making it a promising therapeutic target for ischemic cardiovascular diseases such as peripheral artery disease and coronary artery disease. In this review, we explore both oxygen-dependent and oxygen-independent mechanisms of HIF-1α regulation, the role of the HIF protein family in vessel collateralization, and translational efforts to leverage HIF-1α's pivotal role in hypoxia signaling for the development of clinical treatments for ischemic cardiovascular disease.
APA Citation
Carmichael, Ethan; Reme, Anne-Isabelle S.; Bosco, Patrick J.; Ortiz, Yulexi Y.; Ramos, Daniela Alexandra; Gomez, Katherine; Nguyen, Bao-Ngoc; Bornak, Arash; Liu, Zhao-Jun; and Velazquez, Omaida C., "Biological Regulation of HIF-1α and Its Role in Therapeutic Angiogenesis for Treatment of Ischemic Cardiovascular Disease" (2025). GW Authored Works. Paper 8077.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8077
Department
Surgery